Japan, June 10 -- AMGEN has got intellectual property rights for 'USE OF ONCOLYTIC VIRUSES, ALONE OR IN COMBINATION WITH CHECKPOINT INHIBITOR, FOR TREATMENT OF CANCER.' Other related details are as follows:
Application Number: JP,2025-043270
Category (FI): A61K35/763,A61K45/00,A61P43/00,121,A61P35/00,A61K35/76,A61K39/395@U,A61K39/395@T,C12N7/00
Stage: Grant (IP right document published.)
Filing Date: March 18, 2025
Publication Date: June 24, 2025
The original document can be viewed at: https://www.j-platpat.inpit.go.jp/p0100
Disclaimer: Curated by HT Syndication.
